BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10880258)

  • 1. IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a.
    Gray SG; Svechnikova I; Hartmann W; O'Connor L; Aguilar-Santelises M; Ekström TJ
    Cytokine; 2000 Jul; 12(7):1104-9. PubMed ID: 10880258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells.
    Gray SG; Yakovleva T; Hartmann W; Tally M; Bakalkin G; Ekström TJ
    Exp Cell Res; 1999 Dec; 253(2):618-28. PubMed ID: 10585285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells.
    Gray SG; Ekström TJ
    Biochem Biophys Res Commun; 1998 Apr; 245(2):423-7. PubMed ID: 9571167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
    Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
    Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
    Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice.
    Choi JH; Nam KH; Kim J; Baek MW; Park JE; Park HY; Kwon HJ; Kwon OS; Kim DY; Oh GT
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2404-9. PubMed ID: 16141407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of histone acetylation in the allelic expression of the imprinted human insulin-like growth factor II gene.
    Hu JF; Oruganti H; Vu TH; Hoffman AR
    Biochem Biophys Res Commun; 1998 Oct; 251(2):403-8. PubMed ID: 9792787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A; Sun JM; Davie JR
    Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells.
    El-Khoury V; Gomez D; Liautaud-Roger F; Trussardi-Régnier A; Dufer J
    Cytometry A; 2004 Dec; 62(2):109-17. PubMed ID: 15517561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of histone acetylation on transcriptional regulation of manganese superoxide dismutase gene.
    Maehara K; Uekawa N; Isobe K
    Biochem Biophys Res Commun; 2002 Jul; 295(1):187-92. PubMed ID: 12083788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
    Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
    Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation.
    Sng JC; Taniura H; Yoneda Y
    Neurosci Lett; 2005 Oct; 386(3):150-5. PubMed ID: 16002216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 3 represses HTLV-1 tax transcription.
    Villanueva R; Iglesias AH; Camelo S; Sanin LC; Gray SG; Dangond F
    Oncol Rep; 2006 Sep; 16(3):581-5. PubMed ID: 16865259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
    Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
    Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures.
    Mai A; Massa S; Ragno R; Cerbara I; Jesacher F; Loidl P; Brosch G
    J Med Chem; 2003 Feb; 46(4):512-24. PubMed ID: 12570373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.